ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Beyond Microarrays: Insights from Ncounter Transcript Analysis of Routine Archival Kidney Allograft Biopsies

    I. Rosales, K. Tomaszewski, A. Milagros, T. Kawai, R. Smith, R. Colvin

    Massachusetts General Hospital, Boston, MA

    *Purpose: Microarray mRNA analysis of renal allograft biopsies has discovered important insights, but has limitations as a practical clinical test. Here we evaluate a new…
  • 2021 American Transplant Congress

    Intrarenal B-cell Activating Factor (BAFF) Levels are Increased in Transplant Glomerulopathy

    S. Panzer, K. Swanson, G. Pandya, L. Hidalgo, S. Reese

    University of Wisconsin Madison, Madison, WI

    *Purpose: Transplant glomerulopathy (TG), a key feature of chronic active antibody-mediated rejection (caABMR), is associated with allograft failure. B-cell activating factor (BAFF) is a cytokine…
  • 2021 American Transplant Congress

    Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation: A Single Center Experience with >800 Biopsies

    B. Rocque1, A. Zaldana1, C. Weaver2, J. Huang1, A. Barbetta1, V. Shakhin2, C. Goldbeck1, G. Yanni2, R. Kohli2, Y. Genyk1, J. Emamaullee1

    1Surgery, University of Southern California Keck School of Medicine, Los Angeles, CA, 2Pediatrics, Children’s Hospital-Los Angeles, Los Angeles, CA

    *Purpose: While pediatric liver transplantation (LT) results in excellent long-term outcomes, a high incidence of early acute cellular rejection (ACR) and late graft fibrosis persists.…
  • 2021 American Transplant Congress

    A Patient-Centered Perspective on Progress in Transplantation

    B. Hickner1, N. Galvan2, R. Cotton2, C. O'Mahony2, J. Goss2, A. Rana2

    1Department of Student Affairs, Baylor College of Medicine, Houston, TX, 2Department of Surgery, Baylor College of Medicine, Houston, TX

    *Purpose: This study aimed to provide a patient-centered perspective on change in transplantation outcomes through analysis of intent-to-treat survival, which accounted for donor shortages by…
  • 2021 American Transplant Congress

    Interruption of Notch Signaling via Blockade of Delta-Like Ligand 4 Prevents Co-Stimulation Blockade Resistant Allograft Rejection

    A. J. Matar, B. P. Lovasik, Y. Dong, D. A. Faber, J. Habib, C. Breeden, J. Regenold, A. Ghosh, A. Stephenson, W. H. Kitchens, A. B. Adams

    Emory University Department of Surgery, Atlanta, GA

    *Purpose: Co-stimulation blockade (CoB) has emerged as a promising immunosuppression strategy with the advent of Belatacept, a novel CTLA4-Ig fusion protein that blocks CD28-mediated T…
  • 2021 American Transplant Congress

    Prospective Intensive Monitoring for Anamnestic DSA Responses Allows Near Elimination of Early Clinical AMR

    M. McGowan1, A. Bickenbach1, A. R. Shields2, R. R. Alloway1, P. Brailey1, E. Portwood1, C. Alquist1, A. Christianson1, B. Abu Jawdeh1, M. Cuffy1, J. Kremer2, S. Bumb1, A. Govil1, M. Anand1, T. Kaur1, E. S. Woodle1

    1U Cincinnati, Cincinnati, OH, 2Christ Hospital, Cincinnati, OH

    *Purpose: Anamnestic donor specific antibody (aDSA) responses can result in severe, graft threatening antibody-mediated rejection (AMR). We hypothesized that intensive DSA monitoring (IDM) for aDSA…
  • 2021 American Transplant Congress

    Racial and Sexual Disparities in Solid Organ Transplant Outcomes Since Implementation of the Affordable Care Act Insurance Expansion Across Some States

    H. Mohamed1, C. Conceicao2, A. Kumar1, J. Buggs3

    1Morsani College of Medicine, University of South Florida, Tampa, FL, 2Honors College, University of South Florida, Tampa, FL, 3Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: Achieving solid organ transplantation traditionally requires access to health insurance. As such, women and people of color have faced barriers to obtaining solid-organ transplants.…
  • 2021 American Transplant Congress

    Comprehensive Utilization of HCV Viremic and Non-Viremic Donor Livers and Kidneys into HCV-negative Patients

    M. E. de Vera, J. Woloszyn, J. Sterris, M. Robinson, R. Evans, S. Blais, B. Elhazin, C. Amador, c. Berk, M. Volk, R. Villicana

    Transplant Institute, Loma Linda University Health, San Bernardino, CA

    *Purpose: We report our experience on virologic and graft outcomes of HCV-negative patients transplanted with HCV NAT+ (viremic) and HCV Ab+/NAT- (non-viremic) livers and kidneys…
  • 2021 American Transplant Congress

    Outcomes of Abdominal Transplant Recipients Who Receive Organs from Donors with Positive Cultures

    A. Perez Cortes Villalobos, A. Humar, D. Kumar

    University Health Network, Toronto, ON, Canada

    *Purpose: Due to limited organ availability, use of donors with positive bacterial cultures is common practice. One of the main concerns is transmission to the…
  • 2021 American Transplant Congress

    Are Pre-Transplant Diabetics on ACE Inhibitors at Risk for More Renal Dysfunction After Heart Transplantation?

    M. Kittleson, J. Patel, D. Chang, N. Patel, S. Kim, T. Singer-Englar, R. Skorka, A. Hage, L. Czer, F. Esmailian, J. A. Kobashigawa

    Cedars-Sinai Smidt Heart Institute, Los Angeles, CA

    *Purpose: Diabetic patients undergoing heart transplantation may be at greater risk of developing kidney dysfunction after heart transplantation due to calcineurin inhibitor (CNI) nephrotoxicity. It…
  • « Previous Page
  • 1
  • …
  • 305
  • 306
  • 307
  • 308
  • 309
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences